Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Fields MeAgain Captures for Each Dose Each dose-related field MeAgain tracks and why it matters
Although past meta-analyses reported substantial reductions in MACE with DPP-4 inhibitors [23], their conclusions were based on studies with small sample sizes and limited numbers of cardiovascular events, which have not been confirmed by the four CVOTs specifically designed to assess the CV safety of DPP-4 inhibitors
PMID: 12 JensenDHAaboeKHenriksenJEVlundAHolstJJMadsbadSet al
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
US$ 24.22
,aspect=ignore)
US$ 29.08
US$ 27.95
